Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: Role in NF-κB activation

Molecular and Cellular Biology

Volumn 16, Issue 12, 1996, Pages 7098-7108

  Devergne, Odile ^a   Hatzivassiliou, Eudoxia ^a   Izumi, Kenneth M ^a   Kaye, Kenneth M ^a   Kleijnen, Maurits F ^a   Kieff, Elliott ^a   Mosialos, George ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MEMBRANE PROTEIN; MUTANT PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR; VIRUS PROTEIN;

ARTICLE; B LYMPHOCYTE; CARBOXY TERMINAL SEQUENCE; CELL PROLIFERATION; CONTROLLED STUDY; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; LATENT VIRUS INFECTION; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN DOMAIN; TRANSCRIPTION INITIATION; VIRUS CELL TRANSFORMATION;

HUMAN HERPESVIRUS 4; STAPHYLOCOCCUS PHAGE 187;

EID: 0029956392     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/mcb.16.12.7098     Document Type: Article

References (42)

1. Banchereau, J., F. Bazan, D. Blanchard, F. Briere, J. P. Galizzi, C. van Kooten, Y. J. Liu, F. Roussel, and S. Saeland. 1994. The CD40 antigen and its ligand. Annu. Rev. Immunol. 12:881-922.
2. Cheng, G., and D. Baltimore. 1996. TANK, a co-inducer with TRAF2 of TNF- and CD40L-mediated NF-κB activation. Genes Dev. 10:963-973.
3. Cheng, G., A. M. Cleary, Z. S. Ye, D. I. Hong, S. Lederman, and D. Baltimore. 1995. Involvement of CRAF1, a relative of TRAF, in CD40 signaling. Science 267:1494-1497.
4. Devergne, O., M. Hummel, H. Koeppen, M. Le Beau, E. C. Nathanson, E. Kieff, and M. Birkenbach. 1996. A novel interleukin-12 p40 related protein induced by latent Epstein-Barr virus infection in B lymphocytes. J. Virol. 70:1143-1153.
5. Estrov, Z., R. Kurzrock, E. Pocsik, S. Pathak, H. M. Kantarjian, T. F. Zipf, D. Harris, M. Talpaz, and B. B. Aggarwal. 1993. Lymphotoxin is an autocrine growth factor for Epstein-Barr virus-infected cell lines. J. Exp. Med. 177: 763-774.
6. Fennewald, S., V. van Santen, and E. Kieff. 1984. Nucleotide sequence of an mRNA transcribed in latent growth-transforming virus infection indicates it may encode a membrane protein. J. Virol. 51:411-419.
7. Franken, M., O. Devergne, M. Rasenzweig, B. Annis, E. Kieff, and F. Wang. 1996. Comparative analysis identifies conserved tumor necrosis factor receptor-associated factor 3 binding sites in the human and simian Epstein-Barr virus oncogene LMP1. J. Virol. 70:7819-7826.
8. Gibbons, D. L., M. Rowe, A. P. Pope, M. Feldmann, and F. M. Brennan. 1994. Lymphotoxin acts as an autocrine growth factor for Epstein-Barr virus transformed B cells and differentiated Burkitt lymphoma cell lines. Eur. J. Immunol. 24:1879-1885.
9. Graham, F. L., and A. J. Van Der Eb. 1973. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52:456-467.
10. Hatzivassiliou, E., P. Cardot, V. Zannis, and A. Mitsialis. Usp - a Drosophila RXRα homolog can mobilize the human thyroid hormone receptor to transactivate the human apolipoprotein A-II promoter. Submitted for publication.
11. Henderson, S., M. Rowe, C. Gregory, D. Croom-Carter, F. Wang, R. Longnecker, E. Kieff, and A. Rickinson. 1991. Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell 65:1107-1115.
12. Hennessy, K., S. Fennewald, M. Hummel, T. Cole, and E. Kieff. 1984. A membrane protein encoded by Epstein-Barr virus in latent growth-transforming infection. Proc. Natl. Acad. Sci. USA 81:7201-7211.
13. Hiutson, A. 1980. The analysis of variance: a basic course. Charles Griffin and Co., London.
14. Hsu, H., H. B. Shu, M. G. Pan, and D. Goeddel. 1996. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell 84:299-308.
15. Hu, H., K. O'Rourke, M. S. Boguski, and V. M. Dixit. 1994. A novel RING finger protein interacts with the cytoplasmic domain of CD40. J. Biol. Chem. 269:30069-30072.
16. Huen, D. S., S. A. Henderson, D. Croom-Carter, and M. Rowe. 1995. The Epstein-Barr virus latent membrane protein-1 (LMP1) mediates activation of NF-κB and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domain. Oncogene 10:549-560.
17. Inui, S., T. Kaisho, H. Kikutani, I. Stamenkovic, B. Seed, E. A. Clark, and T. Kishimoto. 1990. Identification of the intracytoplasmic region essential for signal transduction through a B cell activation molecule, CD40. Eur. J. Immunol. 20:1747-1753.
18. Izumi, K. M., K. M. Kaye, and E. Kieff. 1994. Epstein-Barr virus recombinant molecular genetic analysis of the LMP1 amino-terminal cytoplasmic domain reveals a probable structural role, with no component essential for primary B-lymphocyte growth transformation. J. Virol. 68:4369-4376.
19. Izumi, K. M., K. M. Kaye, and E. Kieff. Unpublished data.
20. Kaye, K., K. Izumi, and E. Kieff. 1993. Epstein-Barr virus latent membrane protein 1 is essential for B lymphocyte transformation. Proc. Natl. Acad. Sci. USA 90:9150-9154.
21. Kaye, K., K. M. Izumi, G. Mosialos, and E. Kieff. 1995. The Epstein-Barr virus LMP1 cytoplasmic carboxy terminus is essential for B lymphocyte transformation; fibroblast cocultivation complements a critical function within the terminal 155 residues. J. Virol. 69:675-683.
22. Kaye, K. M., O. Devergne, J. N. Harada, K. M. Izumi, R. Yalamanchili, E. Kieff, and G. Mosialos. 1996. Tumor necrosis factor receptor associated factor 2 is a mediator of NF-κB activation by latent infection membrane protein 1, the Epstein-Barr virus transforming protein. Proc. Natl. Acad. Sci. USA 93:11085-11090.
23. Kaye, K. M., K. M. Izumi, E. Johannsen, and E. Kieff. Unpublished data.
24. Kieff, E. 1996. Epstein-Barr virus and its replication, p. 2343-2396. In B. N. Fields, D. M. Knipe, P. M. Howley, et al. (ed.), Virology, 3rd ed. Raven Press, Ltd., Philadelphia.
25. Lee, S. Y., C. G. Park, and Y. Choi. 1996. T cell receptor dependent cell death of T cell hybridomas mediated by the CD30 cytoplasmic domain in association with tumor necrosis factor-associated factors. J. Exp. Med. 183: 669-674.
26. Liebowitz, D., J. Mannick, K. Takada, and E. Kieff. 1992. Phenotypes of Epstein-Barr virus LMP1 mutants indicate transmembrane and amino-terminal cytoplasmic domains necessary for effects in B-lymphoma cells. J. Virol. 66:4612-4616.
27. Liebowitz, D., D. Wang, and E. Kieff. 1986. Orientation and patching of the latent infection membrane protein encoded by Epstein-Barr virus. J. Virol. 58:233-337.
28. Liston, P., N. Roy, K. Tamai, C. Lefebvre, S. Baird, G. Cherton-Horvat, R. Farahani, M. McLean, J. E. Ikeda, A. MacKenzie, and R. G. Korneluck. 1996. Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes. Nature (London) 379:349-353.
29. Mann, K. P., D. Staunton, and D. Thorley-Lawson. 1985. Epstein-Barr virus-encoded protein found in plasma membranes of transformed cells. J. Virol. 55:710-720.
30. Mitchell, T., and B. Sugden. 1995. Stimulation of NF-κB-mediated transcription by mutant derivatives of the latent membrane protein of Epstein-Barr virus. J. Virol. 69:2968-2976.
31. Mosialos, G., M. Birkenbach, R. Yalamanchili, T. VanArsdale, C. Ware, and E. Kieff. 1995. The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell 80:389-399.
32. Mosialos, G., R. Yalamanchili, and E. Kieff. Unpublished data.
33. Rickinson, A., and E. Kieff. 1996. Epstein-Barr virus, p. 2397-2446. In B. N. Fields, D. M. Knipe, P. M. Howley et al. (ed.), Virology, 3rd ed. Raven Press, Ltd., Philadelphia.
34. Robertson, E., and E. Kieff. 1995. Reducing the complexity of the transforming Epstein-Barr virus genome to 64 kilobase pairs. J. Virol. 69:983-993.
35. Rothe, M., M. G. Pan, W. J. Henzel, T. M. Ayres, and D. V. Goeddel. 1995. The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins. Cell 83:1243-1252.
36. Rothe, M., V. Sarma, V. M. Dixit, and D. V. Goeddel. 1995. TRAF2-mediated activation of NF-κB by TNF receptor 2 and CD40. Science 269:1424-1427.
37. Rothe, M., S. C. Wong, W. J. Henzel, and D. V. Goeddel. 1994. A novel family of putative signal transducers associate with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor. Cell 78:681-692.
38. Sarma, V., Z. Lin, L. Clark, B. M. Rust, M. Tewari, R. J. Noelle, and V. M. Dixit. 1995. Activation of the B-cell surface receptor CD40 induces A20, a novel zinc finger protein that inhibits apoptosis. J. Biol. Chem. 270:12343-12346.
39. Sato, T., S. Irie, and J. C. Reed. 1995. A novel member of the TRAF family of putative signal transducing proteins binds to the cytosolic domain of CD40. FEBS Lett. 358:113-118.
40. Smith, D. B., and K. S. Johnson. 1988. Single-step purification of polypeptides expressed in Escherichia coli as fusion proteins with glutathione S-transferase. Gene 67:31-40.
41. Wang, D., D. Liebowitz, F. Wang, C. Gregory, A. B. Rickinson, R. Larson, T. Springer, and E. Kieff. 1988. Epstein-Barr virus latent infection membrane protein alters the human B-lymphocyte phenotype: deletion of the amino terminus abolishes activity. J. Virol. 62:4173-4184.
42. Wang, F., C. Gregory, J. Sample, M. Rowe, D. Liebowitz, R. Murray, A. Rickinson, and E. Kieff. 1990. Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23. J. Virol. 64:2309-2318.